Reviews
Home-Based Exercise in Cancer Survivors Exposed to Cardiotoxic Therapy: A Meta-Analysis
Wang et alSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

A systematic review and meta-analysis evaluated the effectiveness of structured home-based exercise (HBE) programmes on cardiorespiratory fitness and cancer treatment-related cardiovascular toxicity (CTR-CVT) among cancer survivors exposed to cardiotoxic therapies. Searching seven electronic databases from January 2000 through October 2025, investigators identified 10 randomized controlled trials comprising a total of 851 participants. Primary assessed outcomes encompassed direct cardiotoxicity parameters—such as left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS)—alongside cardiac biomarkers (troponins, B-type natriuretic peptide), clinical cardiovascular events, cardiorespiratory fitness (peak oxygen uptake [VO2 peak]), and functional capacity via the six-minute walk test (6MWT).
The meta-analysis demonstrated that HBE interventions significantly improved VO2 peak (mean difference = 2.35 mL/kg/min, 95% CI: 1.26 to 3.43, p < 0.001), indicating an enhancement in cardiorespiratory fitness. Subgroup evaluations showed larger effect sizes in programs lasting 24 to 52 weeks, those utilizing mHealth support, and trials enrolling patients with stage III/IV cancer. However, the interventions did not produce significant improvements in 6MWT performance or health-related quality of life. Furthermore, evidence addressing direct CTR-CVT parameters and cardiac biomarkers was limited to a single trial, leaving the capacity of home-based exercise to prevent direct cardiovascular toxicity unproven.
Key Takeaways
- A meta-analysis of 10 randomized controlled trials encompassing 851 cancer survivors showed that structured home-based exercise interventions significantly improved peak oxygen uptake compared to control groups (mean difference = 2.35 mL/kg/min, 95% CI: 1.26 to 3.43, p < 0.001).
- Subgroup analyses identified greater cardiorespiratory fitness gains with longer intervention durations (24 to 52 weeks), mobile health (mHealth) integration, and in participants with Stage III/IV cancer.
- Home-based exercise produced no significant improvements in six-minute walk test distance or health-related quality of life, and cardioprotective efficacy against treatment-related cardiotoxicity remains unproven due to direct cardiotoxicity parameters and biomarkers being evaluated in only one study.
Read the original sourceSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
